MedPath

The Effect of Desflurane on Postopertative Cognitive Dysfunction

Phase 4
Conditions
Postoperative Cognitive Dysfunction
Postoperative Delirium
Interventions
Drug: Desflurane
Registration Number
NCT04541823
Lead Sponsor
Beijing Chao Yang Hospital
Brief Summary

The purpose of this study is to determine the effect of desflurane on postoperative cognitive dysfunction

Detailed Description

Postoperative cognitive dysfunction is a common complication during postoperative period,especially in elderly patients. It is characterized by cognitive decline, inattention and abnormal mental status following surgery. The presence of postoperative cognitive dysfunction is independently associated with poor recovery, increased hospital length of stay and increased mortality.

Desflurane is a widely used volatile anesthetic, associated with shorter emergence times than other volatile anesthetics. This study aims to access the effect of desflurane in preventing postoperative cognitive dysfunction.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
    1. Written consent given
    1. Scheduled to undergo elective non-cardiac surgeries under general anesthesia
    1. ASA Physical Score I-III
Exclusion Criteria
    1. Patients with a history of neurological disease, such as Alzheimer disease.
    1. Patients with a history of psychiatric disease
    1. Patients with a medication history of antipsychotic drugs.
    1. Unable to complete neuropsychological testing including patients with severe visual or hearing impairment.
    1. Patients with preoperative delirium.
    1. Patients who have severe adverse events, such as cardiac arrest.
    1. Patients who preoperative MMSE score are below 20;
    1. Patients who undergo second operation in a short period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DesfluraneDesfluranePatients allocated to this arm will receive desflurane during the maintenance of anesthesia.
PropofolPropofolPatients allocated to this arm will receive propofol during the maintenance of anesthesia
Primary Outcome Measures
NameTimeMethod
Incidence of postoperative cognitive dysfunctionon the 30th day after surgery

Screening of the patients regarding an postoperative cognitive dysfunction by TICS-M.TICS-M is assessed at 30 days after surgery

Secondary Outcome Measures
NameTimeMethod
Length of Hospital stayFrom the date of admission until discharged from hospital, within 30 days
Neural and hemodynamic responses during desflurane general anesthesia5 minutes before anesthesia introduction to 5 minutes after emergence

Functional near-infrared spectroscopy (fNIRS) will be monitored from pre-anesthesia to the emergence. △\[HbO\] ,△\[Hb\] will be recorded. Besides, the coupling of fNIRS signals with neuronal signals (EEG) will be calculated. Furthermore, sample entrophy and the phase difference between △\[HbO\] and △\[Hb\] will be measured.

Adverse eventsWithin 30 days after surgery

Other adverse events within 3 days after surgery were noted

Incidence of postoperative nausea and vomitingWithin 7 days after surgery
EEG frequency spectrum5 minutes before anesthesia introduction to 5 minutes before discharge from PACU

Electroencephalography will be recorded at different points of time as follows and EEG characteristics including power in alpha, beta, theta, delta, gamma, spectrum will be extracted using MATLAB:

1. Five minutes before anesthesia introduction

2. During the entire operation

3. At discharge from post-anesthesia care unit (PACU)

Incidence of postoperative delirium1-7days after surgery, on the 30th day after surgery

Screening of the patients regarding a postoperative delirium by The Confusion Assessment Method for The Intensive Care Unit (CAM-ICU)

MortalityWithin 30 days after surgery
Hospital readmissionWithin 30 days after surgery

Hospital readmission during the follow up

Postoperative PainWithin 3 days after surgery

Visual Analogue Scale will be used to assess postoperative pain of patients. Numerical rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain.

Trial Locations

Locations (1)

Beijing Chaoyang Hospital, Capital Medical University

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath